Table 1

Main baseline features of the 13 patients meeting ASAS criteria [30] for axial spondyloarthritis

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7


Type of SpA

AS

AS

AS

AS

AS

AS

AS

Sacroiliitis

Grade 4

Grade 4

Grade 3

Grade 4

Grade 3

Grade 3

Grade 4

HLA-B27

+

+

+

+

+

+

+

Gender

Female

Female

Female

Male

Male

Female

Male

Disease duration (years)

9

27

11

6

4

24

19

Main location of inflammatory pain

Back, neck, chest, peripheral enthesitis (Achilles tendon, knee)

Neck, chest, peripheral enthesitisa

Back, buttock, chest

Neck

Back, neck, buttock

Back, neck, chest

Back, neck, peripheral enthesitis (Achilles tendon)

Concomitant NSAIDs/steroids (dosage)

Yes/no

Yes/no

Yes/no

No/no

No/no

Yes/no

Yes/no

Concomitant DMARDs

No

No

No

Sulfasalazine

No

No

No

Previous biologics other than anti-TNF

Abatacept

Abatacept

Abatacept

No

No

No

No


Patient 8

Patient 9

Patient 10

Patient 11

Patient 12

Patient 13


Type of SpA

AS and PsA

uSpA

uSpA

uSpA

uSpA

uSpA

Sacroiliitis

Grade 3

Grade 1

Grade 0

Grade 0

Grade 0

Grade 0

HLA-B27

-

+

+

+

+

+

Gender

Male

Female

Female

Male

Female

Male

Disease duration (years)

15

11

9

25

6

12

Main location of inflammatory pain

Back, neck, arthritis

Back, neck, buttock, chest

Back, buttock

Back, neck, buttock

Back, buttock, chest, peripheral enthesitis (Achilles tendon)

Back, neck

Concomitant NSAIDs/steroids (dosage)

No/no

Yes/no

Yes/no

No/no

Yes/no

No/yes (25 mg/day)

Concomitant DMARDs

No

No

No

No

No

No

Previous biologics other than anti-TNF

Rituximab

Abatacept

Abatacept

No

No

No


AS, ankylosing spondylitis meeting modified New York criteria [33]; ASAS, Assessment of SpondyloArthritis International Society; DMARD, disease-modifying antirheumatic drug; NSAID, nonsteroidal anti-inflammatory drug; PsA, psoriatic arthritis meeting Classification Criteria for Psoriatic Arthritis [36]; SpA, spondyloarthritis; uSpA, undifferentiated spondyloarthritis. aLocation unknown.

Lekpa et al. Arthritis Research & Therapy 2012 14:R53   doi:10.1186/ar3766

Open Data